BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 25597951)

  • 1. The effect of 1,25 dihydroxyvitamin D3 treatment on the mRNA levels of β catenin target genes in mice with colonic inactivation of both APC alleles.
    DeWitt M; Johnson RL; Snyder P; Fleet JC
    J Steroid Biochem Mol Biol; 2015 Apr; 148():103-10. PubMed ID: 25597951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vitamin D receptor deficiency enhances Wnt/β-catenin signaling and tumor burden in colon cancer.
    Larriba MJ; Ordóñez-Morán P; Chicote I; Martín-Fernández G; Puig I; Muñoz A; Pálmer HG
    PLoS One; 2011; 6(8):e23524. PubMed ID: 21858154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of 1,25-dihydroxyvitamin D3 on the Wnt pathway in non-malignant colonic cells.
    Gröschel C; Aggarwal A; Tennakoon S; Höbaus J; Prinz-Wohlgenannt M; Marian B; Heffeter P; Berger W; Kállay E
    J Steroid Biochem Mol Biol; 2016 Jan; 155(Pt B):224-30. PubMed ID: 25777538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Temporal changes in tissue 1α,25-dihydroxyvitamin D3, vitamin D receptor target genes, and calcium and PTH levels after 1,25(OH)2D3 treatment in mice.
    Chow EC; Quach HP; Vieth R; Pang KS
    Am J Physiol Endocrinol Metab; 2013 May; 304(9):E977-89. PubMed ID: 23482451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Constitutively active RAS signaling reduces 1,25 dihydroxyvitamin D-mediated gene transcription in intestinal epithelial cells by reducing vitamin D receptor expression.
    DeSmet ML; Fleet JC
    J Steroid Biochem Mol Biol; 2017 Oct; 173():194-201. PubMed ID: 28104492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The inhibition of Wnt/beta-catenin signalling by 1alpha,25-dihydroxyvitamin D3 is abrogated by Snail1 in human colon cancer cells.
    Larriba MJ; Valle N; Pálmer HG; Ordóñez-Morán P; Alvarez-Díaz S; Becker KF; Gamallo C; de Herreros AG; González-Sancho JM; Muñoz A
    Endocr Relat Cancer; 2007 Mar; 14(1):141-51. PubMed ID: 17395983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A role for the vitamin D pathway in non-intestinal lesions in genetic and carcinogen models of colorectal cancer and in familial adenomatous polyposis.
    Bong YS; Assefnia S; Tuohy T; Neklason DW; Burt RW; Ahn J; Bueno De Mesquita PJ; Byers SW
    Oncotarget; 2016 Dec; 7(49):80508-80520. PubMed ID: 27768599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 1,25-Dihydroxyvitamin D3 up-regulates the renal vitamin D receptor through indirect gene activation and receptor stabilization.
    Healy KD; Frahm MA; DeLuca HF
    Arch Biochem Biophys; 2005 Jan; 433(2):466-73. PubMed ID: 15581603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reciprocal role of vitamin D receptor on β-catenin regulated keratinocyte proliferation and differentiation.
    Hu L; Bikle DD; Oda Y
    J Steroid Biochem Mol Biol; 2014 Oct; 144 Pt A():237-41. PubMed ID: 24239508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vitamin D receptor ligands, adenomatous polyposis coli, and the vitamin D receptor FokI polymorphism collectively modulate beta-catenin activity in colon cancer cells.
    Egan JB; Thompson PA; Vitanov MV; Bartik L; Jacobs ET; Haussler MR; Gerner EW; Jurutka PW
    Mol Carcinog; 2010 Apr; 49(4):337-52. PubMed ID: 20043299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An Inducible, Large-Intestine-Specific Transgenic Mouse Model for Colitis and Colitis-Induced Colon Cancer Research.
    Wang F; Johnson RL; Snyder PW; DeSmet ML; Fleet JC
    Dig Dis Sci; 2016 Apr; 61(4):1069-79. PubMed ID: 26631394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vitamin D receptor activation down-regulates the small heterodimer partner and increases CYP7A1 to lower cholesterol.
    Chow EC; Magomedova L; Quach HP; Patel R; Durk MR; Fan J; Maeng HJ; Irondi K; Anakk S; Moore DD; Cummins CL; Pang KS
    Gastroenterology; 2014 Apr; 146(4):1048-59. PubMed ID: 24365583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vitamin D and Wnt/beta-catenin pathway in colon cancer: role and regulation of DICKKOPF genes.
    Pendás-Franco N; Aguilera O; Pereira F; González-Sancho JM; Muñoz A
    Anticancer Res; 2008; 28(5A):2613-23. PubMed ID: 19035286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reprint of "Vitamin D deficiency in pregnant women impairs regulatory T cell function".
    Vijayendra Chary A; Hemalatha R; Seshacharyulu M; Vasudeva Murali M; Jayaprakash D; Dinesh Kumar B
    J Steroid Biochem Mol Biol; 2015 Apr; 148():194-201. PubMed ID: 25644204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inactivation of the vitamin D receptor in APC(min/+) mice reveals a critical role for the vitamin D receptor in intestinal tumor growth.
    Zheng W; Wong KE; Zhang Z; Dougherty U; Mustafi R; Kong J; Deb DK; Zheng H; Bissonnette M; Li YC
    Int J Cancer; 2012 Jan; 130(1):10-9. PubMed ID: 21328347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Losartan and Vitamin D Inhibit Colonic Tumor Development in a Conditional Apc-Deleted Mouse Model of Sporadic Colon Cancer.
    Dougherty U; Mustafi R; Haider HI; Khalil A; Souris JS; Joseph L; Hart J; Konda VJ; Zhang W; Pekow J; Li YC; Bissonnette M
    Cancer Prev Res (Phila); 2019 Jul; 12(7):433-448. PubMed ID: 31088824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calciotrophic hormones and hyperglycemia modulate vitamin D receptor and 25 hydroxyy vitamin D 1-α hydroxylase mRNA expression in human vascular smooth muscle cells.
    Somjen D; Knoll E; Sharon O; Many A; Stern N
    J Steroid Biochem Mol Biol; 2015 Apr; 148():210-3. PubMed ID: 25448744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered pharmacokinetics of 1alpha,25-dihydroxyvitamin D3 and 25-hydroxyvitamin D3 in the blood and tissues of the 25-hydroxyvitamin D-24-hydroxylase (Cyp24a1) null mouse.
    Masuda S; Byford V; Arabian A; Sakai Y; Demay MB; St-Arnaud R; Jones G
    Endocrinology; 2005 Feb; 146(2):825-34. PubMed ID: 15498883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Snail2 cooperates with Snail1 in the repression of vitamin D receptor in colon cancer.
    Larriba MJ; Martín-Villar E; García JM; Pereira F; Peña C; de Herreros AG; Bonilla F; Muñoz A
    Carcinogenesis; 2009 Aug; 30(8):1459-68. PubMed ID: 19502595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vitamin D(3) promotes the differentiation of colon carcinoma cells by the induction of E-cadherin and the inhibition of beta-catenin signaling.
    Pálmer HG; González-Sancho JM; Espada J; Berciano MT; Puig I; Baulida J; Quintanilla M; Cano A; de Herreros AG; Lafarga M; Muñoz A
    J Cell Biol; 2001 Jul; 154(2):369-87. PubMed ID: 11470825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.